Kongressthemen With commitments to advancing your preclinical and translational oncology research, we are delighted to bring the 9th annual PREDiCT: Tumor Models Cell Therapy Summit to your screens in July.
See best-in-class tumor models and how they can be effectively utilized to model the tumor microenvironment and further your MoA understanding for new cell therapies.
Kongressorganizer (PCO) Caitlin Napleton
Anmerkungen Speakers: Ganesh Mugundu, Head of Cell Therapy Clinical Pharmacology and Modelling, Takeda, Rekha Pal, Director and Scientific Engagement, Crown Bioscience, Aaron Goldman, Director, Drug Resistance Group, Harvard Medical School and more.